Regulatory Overhaul The Pakistani government has decided in principle to limit the powers of the Drug Regulatory Authority of Pakistan (Drap) and establish a new, independent body specifically tasked with overseeing the pricing of life-saving drugs. This move aims to address ongoing issues with drug shortages and pricing efficiency. Industry Reaction The Pakistan Pharmaceutical Manufacturers’ Association (PPMA) has welcomed the …
Read More »